CRL

314.3104.15%
RK

Reshema Kemps-Polanco

Independent Director

Ms. Reshema Kemps-Polanco serves as an Independent Director at Charles River Laboratories International, Inc. from January 2024. Ms. Kemps-Polanco has extensive pharmaceutical industry experience in leading commercial organizations that will provide a wealth of healthcare business leadership knowledge and sales and marketing expertise to Charles Rivers Board. Ms. Kemps-Polanco has pharmaceutical industry experience and serves as Executive Vice President and Chief Commercial Officer of Novartis US. Prior to rejoining Novartis in 2021, she held several leadership positions at Johnson & Johnson from 2014 until 2021, most recently as President, Janssen U.S. Cardiovascular & Metabolism and Janssen Pharmaceuticals Puerto Rico. She began her pharmaceutical industry career at Novartis in sales and held management positions of increasing responsibility, including leading the U.S. commercial teams marketing strategy for its leukemia franchise and as U.S. brand leader for its osteoporosis therapy. Through her healthcare leadership roles, Ms. Kemps-Polanco is committed to decreasing healthcare inequities in screening and diagnosis and creating equal access to quality healthcare for all patients. She is a board member of the Healthcare Leadership Council (HLC).

Positions